ReNeuron submitted 2 applications to UK regulatory authority to commence multi-site ischemic stroke P2 clinical trial Read more…
RENE will place 181.3M shares in 3 separate tranches at a price of 5.5 pence, a 17% discount to the closing price on 12/10/10 of 6.6 pence raising £10M from investors. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.